Rigel Pharmaceuticals, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS (Tables)

CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS (Tables)

6 Months Ended

Jun. 30, 2024

CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS

Schedule of cash, cash equivalents and short-term investments

Cash, cash equivalents and short-term investments for the periods presented consist of the following (in thousands):


	As of
	June 30, 2024		December 31, 2023
Cash	$	6,126	$	8,247
Money market funds		13,805		9,685
US treasury bills		4,963		12,594
Government-sponsored enterprise securities		10,444		11,233
Corporate bonds and commercial paper		13,764		15,174
	$	49,102	$	56,933
Reported as:
Cash and cash equivalents	$	36,053	$	32,786
Short-term investments		13,049		24,147
	$	49,102	$	56,933

Schedule of cash equivalents and short-term investments including securities with unrealized gains and losses

Cash equivalents and short-term investments include the following securities with gross unrealized gains and losses (in thousands):


			Gross		Gross
	Amortized		Unrealized		Unrealized
As of June 30, 2024	Cost		Gains		Losses		Fair Value
US treasury bills	$	4,963	$	—	$	—	$	4,963
Government-sponsored enterprise securities		10,446		—		(2)		10,444
Corporate bonds and commercial paper		13,771		—		(7)		13,764
Total	$	29,180	$	—	$	(9)	$	29,171


			Gross		Gross
	Amortized		Unrealized		Unrealized
As of December 31, 2023	Cost		Gains		Losses		Fair Value
US treasury bills	$	12,591	$	3	$	—	$	12,594
Government-sponsored enterprise securities		11,230		7		(4)		11,233
Corporate bonds and commercial paper		15,172		5		(3)		15,174
Total	$	38,993	$	15	$	(7)	$	39,001

Schedule of fair value and gross unrealized losses of investments in unrealized loss position

The following table shows the fair value and gross unrealized losses of our investments in individual securities that are in an unrealized loss position, aggregated by investment category (in thousands):


As of June 30, 2024	Fair Value		Unrealized Losses
Government-sponsored enterprise securities	$	9,694	$	(2)
Corporate bonds and commercial paper		13,265		(7)
Total	$	22,959	$	(9)